<p/><br></br><p><b> About the Book </b></p></br></br>Preceded by: Hypertrophic cardiomyopathy / by Barry J. Maron, Lisa Salberg. 2nd ed. 2006.<p/><br></br><p><b> Book Synopsis </b></p></br></br><p>Written by the authority on hypertrophic cardiomyopathy (HCM) and an HCM patient, and fully endorsed by the Hypertrophic Cardiomyopathy Association (HCMA), the leading advocacy and support organization, the 3rd Edition of this best-selling guide offers unparalleled insight into all aspects of living with and treating HCM.</p> <p>Accessible and practical, <b>A Guide to Hypertrophic Cardiomyopathy For Patients, Their Families and Interested Physicians 3rd Edition: </b></p> <ul> <li>Answers the most pressing questions posed by patients, their families, and non-specialists<br />health professionals involved in their care</li> <li>Covers everything from what is HCM and initial diagnosis of this increasingly prevalent<br />condition to the latest treatment options</li> <li>Reflects the first-ever HCM guidelines published by the American Heart Association in 2011</li> </ul> <br /><br /><br /><p/><br></br><p><b> From the Back Cover </b></p></br></br><p>Hypertrophic cardiomyopathy (HCM) is the most common genetic heart disease, but has been under-recognized and often misrepresented. However, more recently, the understanding of HCM has evolved and options for diagnosis and treatment have advanced considerably. HCM can now be regarded as a contemporary and treatable disease, compatible with normal or extended longevity.</p> <p>This book was written by <b>Dr. Barry J. Maron</b>, an authority on HCM, and <b>Ms. Lisa Salberg</b>, Founder of the Hypertrophic Cardiomyopathy Association (HCMA), and herself an HCM patient. This new 3rd edition provides an important update on advances in diagnosis, emerging treatment options, and advice for patients. It is a unique resource and cornerstone of current educational efforts making practical information about HCM accessible to a wide range of patients and physicians.</p><p/><br></br><p><b> About the Author </b></p></br></br><p><b>Barry J. Maron, MD</b>, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA; and Adjunct Professor of Medicine, Tufts University School of Medicine, Boston, MA, USA; and Adjunct Professor of Medicine, Mayo Medical School, Rochester, MN, USA</p> <p><b>Lisa Salberg</b>, Founder and CEO, Hypertrophic Cardiomyopathy Association (HCMA), Hibernia, NJ, USA</p>